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Strengths and limitations of this study
 ► To our knowledge, this is the largest randomised 
evaluation of a self- directed multimedia consent 
process.
 ► Multimedia consent tools were developed in collab-
oration with community members.
 ► Self- directed multimedia was an acceptable, effi-
cient and effective alternative to traditional consent 
processes in medical research.
 ► Generalisability of the findings will need to be con-
firmed in further studies.
AbStrACt
Objective Obtaining informed consent is a cornerstone 
requirement of conducting ethical research. Traditional 
paper- based consent is often excessively lengthy and 
may fail to achieve the desired participant understanding 
of study requirements. Multimedia tools including video 
and audio may be a useful alternative. This study aimed to 
determine the efficacy, usability and acceptability of self- 
directed multimedia delivery of participant consent.
Design It is a single- centre, randomised, prospective 
study to determine the efficacy, usability and acceptability 
of a self- directed multimedia consent process 
(intervention) compared with the traditional paper- based 
approach (control). The intervention was free of research 
staff, with computer- based finger- signed consent.
Setting Pathology blood collection services in Tasmania, 
Australia.
Participants 298 participants (63±8 years; 51% 
female individuals) referred from general practice were 
randomised to intervention (n=146) and control (n=152).
Outcome measures Efficacy, usability and acceptability 
of the allocated consent process were assessed by a 
questionnaire.
results All participants successfully completed the 
allocated interventions. Efficacy parameters were higher 
among intervention participants, including a better 
understanding of study requirements compared with 
controls (p<0.05 all). Intervention participants were 
more likely to engage with the study information and 
spend more time on the consent process (p=<0.001 and 
p=0.006, respectively). Both groups reported similar 
levels of acceptability, although more control participants 
reported that the study information was too long (24% vs 
14%; p=0.020).
Conclusion A self- directed multimedia consent process 
is effective for achieving participant understanding and 
obtaining consent free of research staff. Thus, multimedia 
represents a viable method to reduce the burden on 
researchers, meet participant needs and achieve informed 
consent in clinical research.
IntrODuCtIOn
Informed consent is a cornerstone procedure 
of ethically conducted medical research. 
Consent processes aim to ensure that poten-
tial participants are fully informed prior to 
deciding to take part in the research. Guide-
lines emphasise the need for full disclosure 
of study information including the aims, 
requirements, risks, benefits, funding and 
conflicts of interest, with the view that more 
information facilitates better- informed deci-
sion making.1–3 However, this has resulted in 
lengthy consent processes that are burden-
some for both researchers and participants 
while often failing to achieve the desired level 
of participant understanding.4–11 Indeed, 
as few as 50% of participants understand 
study information, including associated risks 
and that participation is voluntary.5 These 
shortcomings, as well as the emergence of 
complex contemporary methods, including 
biobanking, gene sequencing, linked data, 
remote research and large- scale trials often 
spanning multiple countries, have led to 
calls to update consent guidelines to more 
appropriately reflect the modern research 
landscape.12–15
Self- directed multimedia delivery of infor-
mation via video and audio platforms may 
offer an effective alternative or complemen-
tary tool to traditional consent processes. 
Previous reviews evaluating the efficacy of 
multimedia tools in the consent process 
have been inconclusive.4 16 17 This ambiguity 
may be due to heterogeneous study designs 
and population characteristics. Moreover, 
previous research focused on using multi-
media to augment traditional research 
consent processes, with a researcher present, 
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Figure 1 Flow diagram of study protocol.
rather than multimedia as a standalone and self- directed 
process, making it difficult to discern the generalisability 
and utility of a self- directed multimedia process for 
consent. In any case, there seems to be good acceptability 
and usability of multimedia tools used within the consent 
process with respect to participant satisfaction and facil-
itating recruitment, but also for understanding informa-
tion in a non- research (clinical) setting.16–18
As far as we are aware, there has never been a study to 
determine if consent for participation in research can be 
appropriately delivered in the absence of research staff 
using a self- directed multimedia process compared with 
the traditional paper- based approach in the presence of 
research staff. This study sought to determine this during 
the consent process for people being recruited to partici-
pate in a clinical research project that focused on cardio-
vascular risk assessment.
MethODS
Study protocol
This research was undertaken in the context of a study 
testing the use of a computer- based application (app) to 
gather information for the assessment of absolute cardio-
vascular disease risk within a clinical setting.19 Partici-
pants referred by a general practitioner to pathology 
services were approached for involvement in the cardio-
vascular risk assessment study by the pathology services 
receptionist. Inclusion criteria for participation included 
those with a referral for a full lipid profile aged between 
45 and 74 years in accordance with absolute cardiovas-
cular risk assessment guidelines.20 Participants who were 
interested in involvement in the cardiovascular risk 
assessment study were randomised to receive self- directed 
multimedia consent (intervention) or traditional paper- 
based consent with a researcher (control) (figure 1). Due 
to the setting of the study, field notes were used to collect 
data on why participants did not take part after initial 
eligibility screening.
Both groups received a short demonstration on how to 
use the app. The demonstration was quick with rudimen-
tary instructions provided as it was intended to be deliv-
ered by pathology staff in under a minute who would then 
resume normal clinical duties. The intervention group was 
shown how to play the study video and audio and advised 
to engage with the information until they had decided if 
they wanted to take part, at which point they could provide 
their consent or leave without taking part. The control 
group was provided with the paper- based information 
sheet by a researcher, advised to read and asked if they 
needed assistance or had any questions as per conven-
tional consent processes. Both groups provided signed 
consent using their finger on a touchscreen monitor 
via the app to proceed to the cardiovascular assessment. 
Immediately after the app cardiovascular risk assessment, 
each participant was asked to complete a questionnaire 
to evaluate the efficacy, usability and acceptability of the 
consent process they had undertaken.
randomisation
Referred patients who met the criteria for participation 
received a postcard that contained basic information 
about the study and contact details for more information 
(online supplementary 1, Study postcard). A total of 831 
participants were identified as eligible for participation in 
the cardiovascular risk assessment study; from these, 303 
were randomised to participate (figure 2). Randomisation 
was determined by a computer program on a 1:1 ratio 
prior to recruitment. It was not possible to blind partici-
pants to their allocated interventions because multimedia 
was obviously different from paper- based consent.
Delivery of paper-based consent process as the study control
Control participants received a two- page paper- based 
study participant information sheet compliant with 
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Figure 2 Participant flow diagram.
the requirements of the National Health and Medical 
Research Council and Australian Research Council, 
National Statement on Ethical Conduct in Human 
Research.1 The first page provided information on the 
aims, participation requirements and why participants 
were invited to take part. The second page detailed the 
risks, benefits, funding sources, ethical approval and 
privacy protections. The control consent process involved 
the participant being asked to read the information sheet 
in the presence of a researcher who provided further 
information and answered questions as requested (as per 
usual practice).
Delivery of multimedia consent process as the study 
intervention
Intervention participants received study participation 
information via multimedia approach using a 3 min 
animated video and separate audio content using the 
same terminology and content as the paper- based study 
participant information sheet. The study video was 
congruent with the first page of the information sheet 
and focused on the aims and requirements of the study 
(online supplementary 2, Study video). The separate 
audio content was congruent with the second page of the 
information sheet and provided information on study 
funding, ethical approval, risks and benefits associated 
with participation and privacy protection, which was 
clearly labelled. Each audio segment was approximately 
30 s in duration. Participants were shown how to play the 
audio content as part of the app demonstration. A multi-
disciplinary team of research staff, graphic designers and 
communications staff developed the study video through 
an iterative approach including feedback from commu-
nity members typical of the target demographic.
Patient and public involvement
Community members reviewed and contributed to all 
aspects of study materials including the questionnaires, 
multimedia and paper- based study information and 
advised on the content that was included in the final 
version. An iterative process was undertaken with commu-
nity advisors to develop consent materials, with initial 
drafts completed by researchers. Community advisors 
provided several rounds of feedback (and final approval) 
on all consent materials, including the information sheet, 
postcard, video and audio recordings.
Setting and consent environment
All study procedures took place on the premises of 
pathology services. A purpose- built booth was designed 
for the study (figure 1). The study booth provided a 
private environment for the consent process and clin-
ical data collection. The booth contained a bench with 
the computer that delivered the study app, a chair and a 
curtain for privacy.
Assessment of consent process
The evaluation questionnaire was delivered by a researcher 
at a separate workstation after participants completed all 
study processes in the booth. A 12- item questionnaire was 
used to assess efficacy, usability and acceptability of the 
consent process. The questionnaire was mixed methods 
with dichotomous and multiple- choice questions, each 
with a comment box for open- ended responses.
Efficacy and usability of the consent process
The effectiveness of the allocated consent processes to 
inform participants about the study was assessed via two 
measures: (1) the extent to which participants under-
stood participation was voluntary and (2) participant 
understanding of specific aspects of study participation 
by true or false questions. Four measures denoting user- 
friendliness of the allocated consent processes were used 
to indicate usability: (1) participant engagement with 
the study information by reading, watching or listening; 
(2) participant perceived understanding of the study; 
(3) successful completion of the consent process and 
(4) the time taken to complete the consent process. The 
app automatically recorded the time for both groups 
as the app set- up and demonstration took place before 
the consent process. The time included the set- up, the 
consent process and the cardiovascular assessment ques-
tionnaire. All other parameters were measured by a self- 
report questionnaire.
Acceptability of the consent process
Three indicators of acceptability of the consent process 
were used: (1) was there sufficient information available 
to give consent, (2) were participants satisfied with the 
length of the study information; and (3) what was the 
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Table 2 Efficacy and usability of the informed consent process of study participants randomised to multimedia intervention or 
control delivery of study information and informed consent
Variable
Control
(n=152)
Intervention
(n=146) P value
Efficacy, participants understood   
  Taking part was completely voluntary, n (% yes) 150 (99) 144 (99) 0.167
  The right to withdraw from the study at any time, n (% correct) 143 (94) 136 (93) 0.893
  Baseline participation requirements, n (% correct) 149 (98) 144 (99) 0.090
  Follow- up participation requirements, n (% correct) 82 (54) 118 (87) <0.001
  Data sharing with referring practitioner, n (% correct) 132 (87) 136 (93) 0.025
Usability   
  Engaged with the study information, n (%) 106 (70) 117 (80) <0.001
  Perceived understanding of the study could be improved, n (%) 28 (18) 16 (11) 0.077
  Successfully completed the consent process, n (%) 152 (100) 146 (100) 1
  Total duration (min) (range) 8.4 (2.1–30.5) 9.6 (3.3–17.3) 0.006
Data are expressed as percentages of the group total. P values relate to the χ2 test used for the comparison of categorical variables and t- test 
was used for continuous variables.
Table 1 Sociodemographic and clinical characteristics of 
study participants randomised to multimedia intervention or 
control delivery of study information and informed consent
Variable
Control
(n=152)
Intervention
(n=146)
Age (years) 63±8 63±7
Male, n (%) 76 (50) 70 (48)
Education, n (%)     
  High school 37 (24) 31 (21)
  Certificate, diploma or 
apprenticeship
24 (16) 31 (21)
  University degree or 
higher
81 (53) 76 (52)
Employment, n (%)     
  Employed 67 (44) 64 (44)
  Retired 56 (37) 58 (37)
  Other 18 (12) 13 (9)
Ethnicity, n (%)     
  White 131 (86) 131 (90)
  Aboriginal or Torres 
Strait Islander
1 (1) 2 (1)
  Asian 3 (1) 4 (2)
  Other 3 (1) 1 (1)
Data are expressed as a percentage of the total sample size or 
mean±SD. Response rates varied from 135 to 152 for control and 
133 to 146 for intervention.
No significant differences were observed between the groups.
preferred method of information delivery for deciding to 
take part in the research.
Data analysis
Data are presented as mean and SD or percentage of the 
total sample. For the comparison of categorical variables, 
percentage differences were tested using the χ2 test; the 
t- test was used for continuous variables. For all statis-
tical tests, a p value of <0.05 was considered significant. 
The analysis was conducted by a researcher blinded to 
allocation. Analyses were performed using Stata V.16.1 
(StataCorp).
reSultS
Participant characteristics
There were no differences in sociodemographic char-
acteristics between the intervention and control groups 
(table 1). Participants were predominantly white and 
middle- older aged. Half of the participants had completed 
an undergraduate degree or higher, and a quarter was in 
full- time employment. From field notes, the main reason 
participants did not progress from eligibility screening to 
study participation was due to time constraints as many 
were attending pathology services before going to work.
efficacy and usability of multimedia intervention versus 
control
Intervention participants demonstrated a better under-
standing of the follow- up requirements and data sharing 
practices of the study compared with control participants 
(table 2, p<0.001 and p=0.025, respectively). Intervention 
participants were more likely to spend more time on the 
consent process and study questionnaire (p=0.006). Alto-
gether, more intervention participants engaged with any 
form of study information compared with control partic-
ipants. However, when the section of the information 
sheet that was congruent with the audio component was 
compared, only 9% of intervention participants listened 
to the separate audio and 35% of control participants 
read the second page of the information sheet.
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Table 3 Acceptability of participant information and informed consent process of study participants randomised to 
multimedia intervention or control delivery of participant information and informed consent
Variable
Control
(n=152)
Intervention
(n=146) P value
Sufficient information was available to provide consent, n (%) 0.558
  Yes 145 (95) 138 (95)
  There was too much 1 (1) 1 (1)
  There was not enough 4 (3) 5 (3)
  Not sure 2 (1) 0
The study information was too long, n (%) 37 (24) 21 (14) 0.020
Preferred method of information delivery, n (%) 0.020
  Paper- based written document 88 (58) 60 (41)
  Multimedia 31 (18) 47 (28)
  A researcher must be present 7 (5) 4 (3)
  No preference 24 (16) 30 (21)
Data are expressed as percentages of the group total. The χ2 test was used for the comparison of categorical variables.
Thirty- seven participants (15 intervention and 22 
control) commented on ways to improve their under-
standing of the study. The themes of these comments 
focused on simplifying the study information sheet, 
adding more information to the study postcard, providing 
a variety of information delivery options for participants 
to choose from and providing participants with updates 
on the research outcomes of the study. Four participants 
in the control group requested assistance with the consent 
process as they did not have their reading glasses to read 
the information sheet. No participants in the interven-
tion group requested assistance.
Acceptability of multimedia intervention versus control
Both groups reported similar levels of acceptability 
(table 3), although more control participants reported 
the study information was too long and had a greater pref-
erence for paper- based information delivery (p=0.020 for 
both). Only 4% of participants reported that a researcher 
must be present for the consent process and there was no 
difference between groups.
DISCuSSIOn
The key finding from this study was that a self- directed 
multimedia consent process free from research staff 
was a suitable mode for delivering study information 
and obtaining informed consent for a clinical research 
study. Additionally, multimedia delivery of study infor-
mation improved participant understanding of aspects 
of study involvement. High acceptability of both consent 
processes was reported in this population of middle- to- 
older aged, community- dwelling adults. These findings 
suggest that multimedia is an acceptable, efficient and 
effective alternative to traditional consent processes in 
medical research.
The evidence on using multimedia to enhance the tradi-
tional consent process has concentrated on participants 
with additional support needs such as low literacy, mental 
health issues or children.21–24 Moreover, previous work 
focused on augmenting the traditional consent approach 
with multimedia tools, rather than comparing a truly self- 
directed, multimedia consent process, as we have done in 
this study. Our study design fulfils an identified research 
gap on the need for high- quality comparisons of self- 
directed multimedia delivery of consent compared with 
the traditional approach for research.17 One small study 
assessed the effectiveness of self- directed multimedia 
information delivery, but this was in the setting of consent 
for surgery rather than research participation. In that 
study, they found that 98% of multimedia participants 
understood the information provided compared with 
88% that received conventional verbal consent.18 Our 
findings, in a middle- to- older population without specific 
support needs, further develop this knowledge beyond a 
special population and in a larger sample to confirm that 
a self- directed multimedia platform may be useful among 
populations without special needs, such as community- 
dwelling, older adults (ie, average age 63 years). With the 
potential to enhance current consent processes, further 
work is needed in diverse populations to investigate the 
generalisability of multimedia consent processes.
Ethical conduct is paramount in medical research, 
and consent processes need to adapt to adequately 
reflect modern attitudes and contemporary research 
practices.13–15 This study is relevant to the calls to 
update consent guidelines to better support participant 
autonomy and move away from an unwieldy approach of 
full disclosure, to one that supports values- based decision 
making for participants.13 25 26 As few as 4% of participants 
reported research staff must be present during the consent 
process. Importantly, we observed starkly different levels 
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of participant engagement with study information, with 
only 9% of participants in the multimedia group choosing 
to listen to the separate audio segments on the more tech-
nical aspects of research governance. This indicates that 
engaging with all study information, by reading, watching 
or listening, is not necessarily a priority for making an 
autonomous choice for most participants and is highly 
individual. Accordingly, consent processes, such as we 
have provided, using self- directed multimedia, should 
support participant autonomy by providing options to 
engage with study information relevant to their values to 
aid decision- making processes.
Implications for research and practice
A key benefit of the self- directed consent process evalu-
ated in this research is its potential to improve participant 
understanding of study information while reducing the 
burden of consent for research staff. Another key advan-
tage is the possible economic benefit. Current health-
care consumers and research participants are highly 
‘information- savvy’ and may seek the delivery of informa-
tion from different platforms or prefer diverse options 
for information delivery such as multimedia.27 We suggest 
that the benefits of better delivery of consent informa-
tion will drive cost savings both in the short and longer 
terms. Short- term savings include the cost of time and the 
uptake of information that is more beneficial (and better 
understood) by the participant including understanding 
participation requirements. Longer- term savings could 
include cost savings through widespread uptake of self- 
directed multimedia consent processes to reduce staff 
burden (noting that only four participants asked for staff 
assistance in our study).
Although attempts at standardisation of conven-
tional paper- based consent processes have been made, 
achieving standardised consent delivery by study 
personnel is challenging.1 2 28 Multimedia tools offer an 
inherently standardised method of information delivery, 
as the delivery is predetermined, that would otherwise 
be difficult to achieve in standard consent processes 
undertaken in multisite research projects with large 
staff teams. As demonstrated in this study, a self- directed 
multimedia consent process allows flexibility to engage 
with study information relevant to support participant 
decision making while also ensuring that the delivery 
of that information is standardised for each participant. 
Several publicly available software packages support the 
development and/or delivery of self- directed multimedia 
consent processes and many can also be used to collect 
data as we did in this study (eg, Research Electronic Data 
Capture,29 posing an attractive alternative to current 
consent processes. The findings of this present study high-
light that self- directed multimedia information delivery 
achieves desired levels of participant understanding and 
is as appropriate as the traditional paper- based approach 
for obtaining participant consent. Indeed, in a number 
of settings, it may be more desirable, such as large- scale 
multisite clinical trials.30 31
Strengths and limitations
A key strength of this work is the randomised evaluation 
design among a sizeable study sample, conducted in a 
real clinical setting, and demonstrates the value of this 
approach in a minimal or low- risk research protocol. 
Further work is needed to explore the acceptability and 
appropriateness of consent processes independent of 
research staff before it is implemented for more complex 
research with higher levels of participant risk. Potential 
limitations include the possibility of selection bias as 
participation was by self- selection after initial eligibility 
screening. We cannot be sure whether the findings will be 
generalisable beyond our study population of middle- to- 
older aged, mostly white adults with high levels of educa-
tional attainment, and this will need to be tested in the 
future. Additionally, it was not possible to use validated 
evaluation tools to assess the efficacy, usability and accept-
ability of the consent process due to time constraints 
of undertaking a research protocol within a pathology 
services setting. It was not feasible to notify participants 
about the research prior to presenting at pathology 
services and all participants had to take part on the same 
day their blood sample was collected. For this reason, the 
entire process had to be shorter than 20 min to minimise 
disruption to participants and pathology services. Efficacy, 
usability and acceptability were assessed of the consent 
process as a whole and not specifically of the information 
provided on the second page of the information sheet or 
the separate audio in the multimedia consent process. 
Consequently, we cannot draw definitive conclusions 
on these different aspects of the consent process. Addi-
tionally, the duration of video and audio content was not 
visible to participants before selection, which may have 
deterred some participants from engaging with this infor-
mation and should be rectified in the future.
COnCluSIOn
A self- directed, multimedia consent process free from 
research staff was effective and acceptable to deliver 
participant information and receive informed consent in 
a middle- to- older age population. Our findings suggest 
that multimedia consent processes may be suitable for 
reducing the burden on research staff and improving the 
delivery of consent for research.
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